ChemicalBook > CAS DataBase List > Pritoxaximab

Pritoxaximab

Product Name
Pritoxaximab
CAS No.
1351470-16-0
Chemical Name
Pritoxaximab
Synonyms
Pritoxaximab;Research Grade Pritoxaximab;Research Grade Pritoxaximab(DXX00601)
CBNumber
CB48080880
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Pritoxaximab Chemical Properties,Usage,Production

Uses

Pritoxaximab is an IgG1κ antibody targeting shiga toxin type 1[1].

Pritoxaximab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Pritoxaximab Suppliers

China 15 Global 15
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ：422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
6762
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58
Changsha Fuzhen Biotechnology Co.，LTD
Tel
0731-13823398 15111215862
Email
313359644@qq.com
Country
China
ProdList
4161
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525 17316404525
Email
209533805@qq.com
Country
China
ProdList
9765
Advantage
58
Wanxin Biotechnology (Jiaxing) Co., LTD
Tel
0573-83568680 18057391398
Email
3956524501@qq.com
Country
China
ProdList
1442
Advantage
58

1351470-16-0, PritoxaximabRelated Search:

Tezepelumab Erenumab Cotara (9CI) Refanezumab Pembrolizumab Nipocalimab Fulranumab Pepinemab Penpulimab Robatumumab

  • Pritoxaximab
  • Research Grade Pritoxaximab(DXX00601)
  • Research Grade Pritoxaximab
  • 1351470-16-0